Question to the Department of Health and Social Care:

To ask His Majesty's Government what assessment they have made of the merits of providing weight loss drugs through the National Health Service; to what extent are is this already undertaken; and, if so, in which localities.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

The National Institute for Health and Care Excellence (NICE) makes evidence-based recommendations for the National Health Service on whether new medicines should be routinely funded based on an assessment of their costs and benefits.

NICE has recommended liraglutide, under various brand names, semaglutide, under the brand name Wegovy, and tirzepatide, under the brand name Mounjaro, as treatments for obesity in adults with a high body mass index and with weight related co-morbidities. All medicines are recommended for use in specialist weight management services, with only tirzepatide also recommended for use outside of this setting.

Integrated care boards (ICBs) are legally required to fund and make available medicines recommended by NICE, including obesity medicines, usually within three months of the publication of the final technology appraisal. NICE granted a phased rollout for the use of tirzepatide in primary care to manage NHS resources and allow time to establish new obesity care pathways.

These medicines should therefore be available on the NHS in specialist weight management services, where these services are available, and tirzepatide should have started to become available in primary care from 23 June 2025. We do not hold information on whether each ICB provides access to specific medicines in its locality. ICBs are responsible for ensuring they meet their legal duties, including making funding for NICE-recommended medicines available.

Question to the Home Office:

To ask His Majesty's Government how they intend to take account of the absence of a structure of elected Mayors in Wales in the process of replacing police and crime commissioners.

Answered by Lord Hanson of Flint - Minister of State (Home Office)

We recognise that there are no plans to create elected mayors in Wales and that the devolved nature of local government creates unique circumstances. Whilst we wish to harmonise arrangements across England and Wales as far as possible, we will work with stakeholders in Wales, including the Welsh Government, to ensure the governance model replacing police and crime commissioners provides strong and effective police governance for Wales.

We are establishing transition working groups to consider the design and implementation of the future governance arrangements. One of these will specifically focus on design and implementation in Wales.

Question to the HM Treasury:

To ask His Majesty's Government which of the "lower business rates multipliers" for retail, hospitality and leisure properties with a rateable value of less than £500,000 will be applied in (1) Wales, (2) Scotland, and (3) Northern Ireland; and what discussions they have held with devolved administrations on this matter.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

Business rates is a devolved policy area. Therefore, the new retail hospitality and leisure multipliers will apply in England only.

Question to the HM Treasury:

To ask His Majesty's Government what estimate they have made of the average percentage increase in business rates payable by hospitality properties from April 2026 onwards, set out in Budget 2025, published on 28 November.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

At the Budget, the VOA announced updated property values from the 2026 revaluation. Some properties, including in the retail, hospitality and leisure sectors, have seen their rateable values increased. This is in part because the last revaluation updated rateable values to align with market values on 1 April 2021 – during the CVOID pandemic. This meant rateable values were lower due to the atypical economic situation the pandemic created. This latest revaluation reflects a post Covid world, which has led to significant increases in rateable values for some properties.

To support with bill increases, at the Budget, the Government introduced a support package worth £4.3 billion over the next three years to protect ratepayers seeing their bills increase because of the revaluation. As a result, over half of ratepayers will see no bill increases, including 23% seeing their bills go down. Government support also means that most properties seeing increases will see them capped at 15% or less next year, or £800 for the smallest.

More broadly, the Government is delivering a long overdue reform to rebalance the business rates system and support the high street, as promised in our manifesto. The Government is doing this by introducing permanently lower tax rates for eligible retail, hospitality and leisure (RHL) properties, while ensuring that warehouses used by online giants will pay more. The new RHL tax rates replace the temporary RHL relief that has been winding down since Covid.

Unlike RHL relief, the new rates are permanent, giving businesses certainty and stability, and there will be no cap, meaning all qualifying properties on high streets across England will benefit.

Question to the HM Treasury:

To ask His Majesty's Government what estimate they have made of the total value of Russian Central Bank assets held in the UK.

Answered by Lord Livermore - Financial Secretary (HM Treasury)

Assets belonging to the Central Bank of Russia have been immobilised in the UK and across the G7 through sanctions.

It is important any decision to release detail about the assets is taken on a collective G7 basis.

Question to the Department of Health and Social Care:

To ask His Majesty's Government what is the percentage uptake of flu vaccines in children in each region of England; and what is their target uptake for children this winter.

Answered by Baroness Merron - Parliamentary Under-Secretary (Department of Health and Social Care)

For England, the UK Health Security Agency (UKHSA) publishes provisional vaccine uptake data throughout the flu season.

Monthly regional level data for general practice patients, including two- and three-year-olds and school-aged children, is available throughout the season. The following table shows the provisional vaccine uptake for two- and three-year-olds in England, by region, for the 2025 to 2026 season:

In addition, the following table shows the provisional vaccine uptake for school-aged children in England, by region:

Providers are expected to deliver a 100% offer to eligible groups. They should ensure they make firm plans to equal or improve uptake rates in 2025 to 2026, particularly in those cohorts where uptake has been lower.